Find important updates, industry news, and information on CLSI’s upcoming events. Check out past CLSI press releases, upcoming Committees Week, and newsworthy items.
June 17, 2020
The Clinical and Laboratory Standards Institute (CLSI) has published QMS05— Qualifying, Selecting, and Evaluating a Referral Laboratory, 3rd ed. QMS05 provides laboratories with a defined process to identify candidate referral laboratories and consultants and qualify them for additional consideration.
Read MoreJune 1, 2020
The Clinical and Laboratory Standards Institute has published VET03, Methods for Antimicrobial Broth Dilution and Disk Diffusion Susceptibility Testing of Bacteria Isolated From Aquatic Animals, 2nd Edition and its supplement, VET04, Performance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated From Aquatic Animals, 3rd Edition.
Read MoreJanuary 23, 2020
The Clinical and Laboratory Standards Institute announces the publication of its annually updated antimicrobial susceptibility testing (AST) supplement M100—Performance Standards for Antimicrobial Susceptibility Testing, 30th ed. M100 is available as part of a package with either M02—Performance Standards for Antimicrobial Disk Susceptibility, 13th Ed. or M07— Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 11th Ed., or all three documents together.
Read MoreJanuary 23, 2020
The Clinical and Laboratory Standards Institute announces the recipients of its 2020 Excellence Awards. These awards celebrate the achievements of CLSI volunteers who have helped improve the quality of medical care worldwide.
Read MoreJanuary 21, 2020
The Clinical and Laboratory Standards Institute has published POCT15—Point-of-Care Testing for Infectious Disease. POCT15 is intended for use in assessing, implementing, and managing programs for the detection, control and/or management of infectious diseases using point-of-care testing (POCT) methodologies.
Read MoreJanuary 8, 2020
CLSI Publishes New Method Evaluation Document—EP35—Assessment of Equivalence or Suitability of Specimen Types for Medical Laboratory Measurement Procedures, 1st Edition
Read MoreDecember 23, 2019
The Clinical and Laboratory Standards Institute (CLSI) has published the second edition of NBS05—Newborn Screening for Cystic Fibrosis. NBS05 describes newborn screening (NBS) laboratory tests and screening strategies used worldwide to identify newborns at increased risk of developing cystic fibrosis (CF).
Read MoreNovember 5, 2019
The Clinical and Laboratory Standards Institute (CLSI) has published NBS08—Newborn Screening for Hemoglobinopathies, 1st Edition. NBS08 describes the newborn screening (NBS) processes for testing dried blood spot specimens to detect hemoglobinopathies and thalassemias not usually evident at birth. Hemoglobinopathies and thalassemias are clinically significant congenital red blood cell disorders caused by structural or other hemoglobin abnormalities, resulting in various clinical manifestations.
Read MoreSeptember 12, 2019
The Clinical and Laboratory Standards Institute (CLSI) has published AUTO15—Autoverification of Medical Laboratory Results for Specific Disciplines provides general guidance, as well as discipline-specific direction, on design and validation of an autoverification system. Autoverification is the process by which laboratory analyte results are accepted or rejected for automatic delivery to a patient data repository. This process uses a predetermined set of criteria applied at one or more points during the electronic flow of information. This guideline is provided for use by laboratorians, personnel responsible for information systems, and vendors for medical informatics and in vitro diagnostics.
Read MoreAugust 14, 2019
The Clinical and Laboratory Standards Institute (CLSI) has published NBS03—Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns. NBS03 describes newborn screening (NBS) of preterm, low birth weight (LBW), and sick newborns worldwide to detect treatable diseases before physical damage can occur. In developed countries, treatment advances have improved survival rates, making early disease detection by NBS even more important.
Read More